alpha-Tocopherol: Clinical Trials

18 trials of alpha-Tocopherol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

18 completed. 18 Phase 3, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 318Completed 18
Phase 24Completed 4

Follow alpha-Tocopherol: new trials by email Literature Review of alpha-Tocopherol trials Research Report on alpha-Tocopherol

Trials (filtered) newest first · largest first

All 18 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Hydroxytyrosol and Vitamin E in Pediatric NASH
Hydroxytyrosol plus Vitamin E, Placebo - NAFLD
Phase 3CompletedBambino Gesù Hospital and Research Institute802017-04-012018-07-17
Efficacy of Vitamin E in Preventing Contrast-Induced Acute Kidney Injury Following Coronary Angiography
Vitamin E - Stable Angina, Unstable Angina
Phase 3CompletedUrmia University of Medical Sciences2842014-02-012015-06-16
Vitamin E Supplementation in Burned Patients
Vitamin E - Burn
Phase 2 / Phase 3CompletedThe University of Texas Medical Branch, Galveston272013-02-012026-07-20
Lactation Fortification Study
Similac Prenatal Vitamin soft-gel capsule, Placebo (soybean oil and dl-alpha-tocopheryl acetate) - Lactation
Phase 3CompletedAbbott Nutrition892012-11-012013-05-31
Study of the Absorption of Vitamin E Water-soluble Form (Pegylated) in the Familial Hypocholesterolemia With Chylomicron Retention
Tocofersolan, tocopherol alpha, Tocofersolan and tocopherol alpha - Hypobetalipoproteinemias
Phase 3CompletedHospices Civils de Lyon142011-10-012025-08-22
Trial of Combined Pentoxifylline-tocopherol-clodronate vs Placebo in Radiation-induced Brachial Plexopathy
Pentoxifylline placebo, Pentoxifylline, Tocopherol acetate - Radiation Induced Brachial Plexopathy
Phase 3CompletedAssistance Publique - Hôpitaux de Paris592011-03-012017-12-08
Type 2 Diabetes Haptoglobin Phenotype and Vitamin E
Vitamin E (d-alpha-tocopheryl acetate), Placebo - Diabetes Mellitus Type 2
Phase 2 / Phase 3CompletedTechnion, Israel Institute of Technology902009-01-012011-01-11
S0000D: Effect of Vitamin E and/or Selenium on Colorectal Polyps in Men Enrolled on SELECT Trial SWOG-S0000
Vitamin E, Selenium, Vitamin E placebo - Colorectal Cancer, Precancerous Condition
Phase 3CompletedSWOG Cancer Research Network80942008-06-012019-12-16
Impact of Oral Versatile Antioxidants on Glaucoma Progression
Gingko Biloba, α-tocopherol, Placebo - Glaucoma
Phase 3CompletedBagcilar Training and Research Hospital602008-04-012012-03-05
A Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's Disease
dl-alpha-tocopherol, Memantine, Placebo - Alzheimer's Disease
Phase 3CompletedUS Department of Veterans Affairs6132007-08-012014-07-23
S0000B: Vitamin E and/or Selenium in Preventing Cataract and Age-Related Macular Degeneration in Men on SELECT SWOG-S0000
selenium, vitamin E, vitamin E placebo - Cataract, Macular Degeneration
Phase 3CompletedSWOG Cancer Research Network134752004-07-012019-08-14
Combined Antioxidant and Preeclampsia Prediction Studies (CAPPS)
Dietary Supplement/Vitamins, Placebo for Vitamin C and Vitamin E - Preeclampsia
Phase 3CompletedThe George Washington University Biostatistics Center101542003-06-012019-02-21
Effect of Vitamin E on Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)
Vitamin treatment (alpha tocopherol plus ascorbic acid), Placebo - Inflammation, Fibrosis
Phase 2 / Phase 3CompletedBambino Gesù Hospital and Research Institute902003-01-012008-04-09
S0000 Selenium and Vitamin E in Preventing Prostate Cancer
Vitamin E, Selenium, Vitamin E placebo - Prostate Cancer
Phase 3CompletedSWOG Cancer Research Network355332001-07-012015-11-20
Multicenter Vitamin E Trial in Aging Persons With Down Syndrome
Alpha-Tocopherol, Sugar Pill - Alzheimer's Disease, Down Syndrome
Phase 3CompletedNew York State Institute for Basic Research3492000-09-012012-05-09
VEAPS: Vitamin E Atherosclerosis Prevention Study
DL-alpha-tocopherol - Atherosclerosis
Phase 2 / Phase 3CompletedNational Institute on Aging (NIA)3531996-07-012009-12-11
Effects of High-dose n-3 Fatty Acids on Clinical Outcome and Serum Lipids - Omacor Following Acute Myocardial Infarction
EPA / DHA / Alpha-Tocopherol, Corn Oil / Alpha-Tocopherol (4 mg) - Coronary Disease, Myocardial Infarction
Phase 3CompletedHelse Stavanger HF3001995-09-012012-02-22
Beta-carotene and Alpha-tocopherol Chemoprevention of Second Primary Malignancies in Head and Neck Cancer Patients
Alpha-Tocopherol and Beta-Carotene, Placebo - Neoplasms
Phase 3CompletedLaval University5401994-10-012018-03-14

Conditions studied

Alzheimer Disease (2)  ·  Inflammation (2)  ·  Non-alcoholic Fatty Liver Disease (2)  ·  Adenomatous Polyps (1)  ·  Angina, Stable (1)  ·  Angina, Unstable (1)  ·  Atherosclerosis (1)  ·  Breast Feeding (1)  ·  Burns (1)  ·  Cataract (1)  ·  Cognitive Dysfunction (1)  ·  Colonic Neoplasms (1)  ·  Colorectal Neoplasms (1)  ·  Coronary Disease (1)  ·  Dementia (1)

Sponsors

SWOG Cancer Research Network (3)  ·  Bambino Gesù Hospital and Research Institute (2)  ·  Abbott Nutrition (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Bagcilar Training and Research Hospital (1)  ·  Helse Stavanger HF (1)  ·  Hospices Civils de Lyon (1)  ·  Laval University (1)  ·  National Institute on Aging (NIA) (1)  ·  New York State Institute for Basic Research (1)  ·  Technion, Israel Institute of Technology (1)  ·  The George Washington University Biostatistics Center (1)  ·  The University of Texas Medical Branch, Galveston (1)  ·  US Department of Veterans Affairs (1)  ·  Urmia University of Medical Sciences (1)

Countries

United States (8)  ·  France (2)  ·  Italy (2)  ·  Canada (1)  ·  Iran (1)  ·  Israel (1)  ·  Norway (1)  ·  Puerto Rico (1)  ·  Turkey (Türkiye) (1)

Top investigators

Andrew Levy, MD PhD (1)  ·  Christina Sherry, PhD, RD (1)  ·  Daniel D Karp, M.D. (1)  ·  Dennis WT Nilsen, PhD (1)  ·  Eric Klein, MD (1)  ·  Fadlo R. Khuri, M.D. (1)  ·  Howard F. Andrews, Ph.D. (1)  ·  Howard N. Hodis, MD (1)  ·  Ian M. Thompson, M.D. (1)  ·  Isabelle Bairati, MD, PhD (1)  ·  J. Michael Gaziano, M.D. (1)  ·  James M Roberts, MD (1)  ·  Kaya N Engin, MD,PhD (1)  ·  Laurence H. Klotz, MD (1)  ·  Linda E Sousse, PhD, MBA (1)

Results publications

PMID 27519183, PMID 12234947, PMID 15812073, PMID 16027437, PMID 16841333, PMID 17206944, PMID 17927499, PMID 18059031, PMID 18172254, PMID 19066370, PMID 19451440, PMID 20103685, PMID 20156960, PMID 20187097, PMID 20375405, PMID 20533282, PMID 20733448, PMID 20833684, PMID 21424341, PMID 21640495, PMID 21722898, PMID 21990298, PMID 22009713, PMID 22076708, PMID 22742890, PMID 23064404, PMID 23169318, PMID 23171483, PMID 24381967, PMID 24899160, PMID 25232809, PMID 27068631, PMID 27173062, PMID 27197287, PMID 27998216, PMID 28791297, PMID 30021760, PMID 32312759, PMID 33060043, PMID 42581651

NIH funding

U10CA037429 (3), R01AG013860 (1), R01AG016381 (1), R01EY014418 (1), R03CA141615 (1), U01HD036801 (1), U10HD021410 (1), U10HD027860 (1), U10HD027869 (1), U10HD027915 (1), U10HD027917 (1), U10HD034116 (1), U10HD034136 (1), U10HD034208 (1), U10HD040485 (1)